{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:55:52Z","timestamp":1788904552166,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jss.2020.07.025","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T13:51:11Z","timestamp":1599141071000},"page":"412-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Is Breast Magnetic Resonance Imaging an Accurate Predictor of Nodal Status After Neoadjuvant Chemotherapy?"],"prefix":"10.1016","volume":"257","author":[{"given":"Chandler S.","family":"Cortina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati A.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Karst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2020.07.025_bib1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.07.025_bib2","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2147\/OTT.S151821","article-title":"Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients","volume":"11","author":"Abdel-Razeq","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jss.2020.07.025_bib3","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1245\/s10434-016-5733-y","article-title":"National trends in the use of neoadjuvant chemotherapy for hormone receptor-negative breast cancer: a national cancer data base study","volume":"24","author":"Puig","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2020.07.025_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.jncimonographs.a003469","article-title":"Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18","author":"Wolmark","year":"2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.jss.2020.07.025_bib5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.7150\/jca.23969","article-title":"International consensus on the clinical management of inflammatory breast cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference","volume":"9","author":"Ueno","year":"2018","journal-title":"J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.jss.2020.07.025_bib6","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.3747\/co.22.2328","article-title":"A Canadian national expert consensus on neoadjuvant therapy for breast cancer: linking practice to evidence and beyond","volume":"22","author":"Simmons","year":"2015","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jss.2020.07.025_bib7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","article-title":"Preoperative chemotherapy: updates of national surgical adjuvant breast and Bowel Project protocols B-18 and B-27","volume":"26","author":"Rastogi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.07.025_bib8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.07.025_bib9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2020.07.025_bib10","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1245\/s10434-016-5463-1","article-title":"How often is treatment effect identified in axillary nodes with a pathologic complete response after neoadjuvant chemotherapy?","volume":"23","author":"Barrio","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2020.07.025_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/SLA.0000000000002373","article-title":"Tumor biology and response to chemotherapy impact breast cancer-specific survival in node-positive breast cancer patients treated with neoadjuvant chemotherapy: long-term follow-up from ACOSOG Z1071 (Alliance)","volume":"266","author":"Boughey","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2020.07.025_bib12","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jss.2020.07.025_bib13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jss.2020.07.025_bib14","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its Impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology group Z1071 trial (Alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.07.025_bib15","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2020.07.025_bib16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.07.025_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1148\/radiol.11110814","article-title":"Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging","volume":"261","author":"Chen","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.jss.2020.07.025_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jss.2016.04.048","article-title":"Predictive value of axillary nodal imaging by magnetic resonance imaging based on breast cancer subtype after neoadjuvant chemotherapy","volume":"204","author":"Steiman","year":"2016","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2020.07.025_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jamcollsurg.2017.08.027","article-title":"MRI and prediction of pathologic complete response in the breast and axilla after neoadjuvant chemotherapy for breast cancer","volume":"225","author":"Weber","year":"2017","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2020.07.025_bib20","doi-asserted-by":"crossref","first-page":"20150143","DOI":"10.1259\/bjr.20150143","article-title":"Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and 1\u2078F-FDG PET\/CT","volume":"88","author":"You","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jss.2020.07.025_bib21","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.27995","article-title":"Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017","volume":"119","author":"De Los Santos","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2020.07.025_bib22","author":"Karst"},{"key":"10.1016\/j.jss.2020.07.025_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clbc.2016.11.004","article-title":"Magnetic resonance imaging for axillary breast cancer metastasis in the neoadjuvant setting: a prospective study","volume":"17","author":"Mattingly","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jss.2020.07.025_bib25","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J Clin Oncol"},{"issue":"Supp","key":"10.1016\/j.jss.2020.07.025_bib27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1200\/jco.2012.30.15_suppl.1107","article-title":"Role of axillary ultrasound after neoadjuvant chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis (ACOSOG Z1071)","volume":"15","author":"Le-Petross","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420304820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420304820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:52:57Z","timestamp":1758379977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480420304820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":25,"alternative-id":["S0022480420304820"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2020.07.025","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Breast Magnetic Resonance Imaging an Accurate Predictor of Nodal Status After Neoadjuvant Chemotherapy?","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2020.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}